BioCentury
ARTICLE | Politics, Policy & Law

Gene therapy wins faint praise

December 11, 1995 8:00 AM UTC

WASHINGTON - Gene therapy has been over-hyped, false expectations of rapid progress have been raised, and NIH should shift its spending in the field to basic research, according to a report submitted to NIH Director Harold Varmus.

The report by an ad hoc committee appointed by Varmus to assess the NIH investment in gene therapy was presented last week at a meeting of the Advisory Committee to the Director...